Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Histone-lysine N-methyltransferase EZH2 | ||
Ligand | BDBM50586160 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2165240 (CHEMBL5050101) | ||
IC50 | 208±n/a nM | ||
Citation | Liang, R; Tomita, D; Sasaki, Y; Ginn, J; Michino, M; Huggins, DJ; Baxt, L; Kargman, S; Shahid, M; Aso, K; Duggan, M; Stamford, AW; DeStanchina, E; Liverton, N; Meinke, PT; Foley, MA; Phillips, RE A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors. ACS Med Chem Lett13:377-387 (2022) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Histone-lysine N-methyltransferase EZH2 | |||
Name: | Histone-lysine N-methyltransferase EZH2 | ||
Synonyms: | ENX-1 | EZH2 | EZH2_HUMAN | Enhancer of zeste homolog 2 (EZH2) | Histone-lysine N-methyltransferase EZH2 | KMT6 | Lysine N-methyltransferase 6 | ||
Type: | Protein | ||
Mol. Mass.: | 85367.84 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q15910 | ||
Residue: | 746 | ||
Sequence: |
| ||
BDBM50586160 | |||
n/a | |||
Name | BDBM50586160 | ||
Synonyms: | CHEMBL5085993 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H24Cl2N4O4 | ||
Mol. Mass. | 491.367 | ||
SMILES | COc1cc(C)[nH]c(=O)c1CN1CCN(C)c2c(Cl)cc(-c3c(C)noc3C)c(Cl)c2C1=O |(3.33,-2.71,;2.93,-1.22,;4.02,-.13,;5.51,-.53,;6.6,.56,;8.09,.16,;6.2,2.05,;4.71,2.44,;4.31,3.93,;3.62,1.35,;2.14,1.75,;1.05,.66,;1.72,-.71,;1.05,-2.09,;-.45,-2.44,;-.85,-3.93,;-1.65,-1.48,;-2.98,-2.25,;-2.98,-3.79,;-4.32,-1.49,;-4.32,.05,;-5.65,.82,;-7.06,.2,;-7.45,-1.29,;-8.09,1.34,;-7.32,2.68,;-5.81,2.36,;-4.72,3.44,;-2.98,.82,;-2.98,2.36,;-1.65,.06,;-.46,1.01,;-.85,2.49,)| | ||
Structure |